Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The DAN (differential screening-selected gene aberrative in
neuroblastoma
) family are a group of secreted extracellular proteins which typically bind to and antagonize BMP (bone morphogenetic protein) ligands. Previous studies have revealed discrepancies between the oligomerization state of certain DAN family members, with SOST (a poor antagonist of BMP signaling) forming a monomer while Grem1, Grem2, and NBL1 (more potent BMP antagonists) form non-disulfide linked dimers. The protein
SOSTDC1
(Sclerostin domain containing protein 1) is sequentially similar to SOST, but has been shown to be a better BMP inhibitor. In order to determine the oligomerization state of
SOSTDC1
and determine what effect dimerization might have on the mechanism of DAN family antagonism of BMP signaling, we isolated the
SOSTDC1
protein and, using a battery of biophysical, biochemical, and structural techniques, showed that
SOSTDC1
forms a highly stable non-covalent dimer. Additionally, this
SOSTDC1
dimer was shown, using an in vitro cell based assay system, to be an inhibitor of multiple BMP signaling growth factors, including GDF5, while monomeric SOST was a very poor antagonist. These results demonstrate that
SOSTDC1
is distinct from paralogue SOST in terms of both oligomerization and strength of BMP inhibition.
...
PMID:Characterization of the different oligomeric states of the DAN family antagonists SOSTDC1 and SOST. 3277 97